These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8624103)

  • 1. Functional imaging patterns in Alzheimer's disease. Relationships to neurobiology.
    Jagust WJ
    Ann N Y Acad Sci; 1996 Jan; 777():30-6. PubMed ID: 8624103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease.
    Jagust WJ; Eberling JL; Richardson BC; Reed BR; Baker MG; Nordahl TE; Budinger TF
    Brain Res; 1993 Dec; 629(2):189-98. PubMed ID: 8111623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
    J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can PET data differentiate Alzheimer's disease from vascular dementia?
    Nagata K; Maruya H; Yuya H; Terashi H; Mito Y; Kato H; Sato M; Satoh Y; Watahiki Y; Hirata Y; Yokoyama E; Hatazawa J
    Ann N Y Acad Sci; 2000 Apr; 903():252-61. PubMed ID: 10818514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of Alzheimer's disease with PET.
    Salmon E; Sadzot B; Maquet P; Degueldre C; Lemaire C; Rigo P; Comar D; Franck G
    J Nucl Med; 1994 Mar; 35(3):391-8. PubMed ID: 8113882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of single photon emission computed tomography in Alzheimer's disease.
    Hanyu H; Abe S; Arai H; Asano T; Iwamoto T; Takasaki M
    Gerontology; 1993; 39(5):260-6. PubMed ID: 8314092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography.
    Van Gool WA; Walstra GJ; Teunisse S; Van der Zant FM; Weinstein HC; Van Royen EA
    J Neurol; 1995 Jun; 242(6):401-5. PubMed ID: 7561970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECT and PET imaging in Alzheimer's disease.
    Valotassiou V; Malamitsi J; Papatriantafyllou J; Dardiotis E; Tsougos I; Psimadas D; Alexiou S; Hadjigeorgiou G; Georgoulias P
    Ann Nucl Med; 2018 Nov; 32(9):583-593. PubMed ID: 30128693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
    Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
    Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
    Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
    Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias.
    Masterman DL; Mendez MF; Fairbanks LA; Cummings JL
    J Geriatr Psychiatry Neurol; 1997 Jan; 10(1):15-21. PubMed ID: 9100154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.
    Meltzer CC; Zubieta JK; Brandt J; Tune LE; Mayberg HS; Frost JJ
    Neurology; 1996 Aug; 47(2):454-61. PubMed ID: 8757020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review.
    Rapoport SI
    Cerebrovasc Brain Metab Rev; 1991; 3(4):297-335. PubMed ID: 1772739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment.
    Cappa A; Calcagni ML; Villa G; Giordano A; Marra C; De Rossi G; Puopolo M; Gainotti G
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):22-7. PubMed ID: 11118243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.